Our project entitled """"""""Molecular Immunology of MHC-Restricted T Cell Responses"""""""" aims at understanding the initial events of T cell activation. In order to do so, we will attempt the structure determination of a number of molecules retained in the TCR complex such as CD8ab and CD3 ge and de. Protein engineering will be used to produce single chain CD8-MHC molecules to facilitate crystallization of the CD8-MHC and CD8ab/TCRp-MHC complexes. In addition new crystallization techniques will be attempted for CD8 and CD3 molecules with the usage of viral display. The platform of the N-w virus and CPMV virus will be used for these studies. Also, a large number of Fab-CD3, and Fab- CD8ab complexes will be produced and used for crystallization.
The second aim i s to characterize the lateral interactions of CD3 dimers with T cell receptors by surface plasmon resonance and FRET using monomers and tetramers of the CD3 dimers and purified TCR molecules. Similar studies will be carried out with the pre-TCR and gd TCR. The first two aims will converge and help us into our attempt at reconstituting artificial TCRC in membranes. Observation of these structures will be done by single molecule microscopy in supported bilayers. The association of the different subunits of the TCRC will be studied in supported membranes by total internal reflection microscopy. Recombinant molecules will be labeled in vitro with fluorophores and reattached to membranes through chelating lipids. Interactions between individual components will be measured and compared to affinity numbers in solution. Behavior of reconstituted TCRC will be observed upon ligation with appropriate p-MHC complexes. These dynamic studies will be complemented by attempts at 2-dimensional crystallization of the TCRC. Finally, studies of the pre-TCR and the characterization of its ligand will aim at determining its structure and the structure of its ligand. Recombinant pre-TCR monomers and tetramers will be used to isolate a ligand using advanced proteomics approaches. Expression cloning will be attempted if biochemical techniques fail. Confirmation of ligand identity and binding properties will be studied by using transfection, expression of soluble recombinant forms of the molecule and surface plasmon resonance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI042267-06
Application #
6562166
Study Section
Special Emphasis Panel (ZRG1-EI (02))
Program Officer
Kirkham, Perry M
Project Start
1997-12-01
Project End
2008-03-31
Budget Start
2003-04-15
Budget End
2004-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$667,245
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Komori, H Kiyomi; Witherden, Deborah A; Kelly, Ryan et al. (2012) Cutting edge: dendritic epidermal ýýýý T cell ligands are rapidly and locally expressed by keratinocytes following cutaneous wounding. J Immunol 188:2972-6
Shore, D A; Issafras, H; Landais, E et al. (2008) The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I. J Mol Biol 384:1190-202
Scherer, Erin M; Zwick, Michael B; Teyton, Luc et al. (2007) Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 21:2131-9
Shore, D A; Teyton, L; Dwek, R A et al. (2006) Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution. J Mol Biol 358:347-54
Cantu 3rd, Carlos; Benlagha, Kamel; Savage, Paul B et al. (2003) The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. J Immunol 170:4673-82
Luz, John G; Huang, Mingdong; Garcia, K Christopher et al. (2002) Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions. J Exp Med 195:1175-86
Apostolopoulos, Vasso; Yu, Minmin; Corper, Adam L et al. (2002) Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design. J Mol Biol 318:1293-305
Rudolph, M G; Huang, M; Teyton, L et al. (2001) Crystal structure of an isolated V(alpha) domain of the 2C T-cell receptor. J Mol Biol 314:1-8
Rudolph, M G; Speir, J A; Brunmark, A et al. (2001) The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity 14:231-42
Degano, M; Garcia, K C; Apostolopoulos, V et al. (2000) A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12:251-61

Showing the most recent 10 out of 18 publications